Navigation Links
Mindray Announces First Quarter 2009 Financial Results
Date:5/11/2009

ition of Datascope patient monitoring business.

The company's practice is to provide guidance on a full year basis only. This forecast reflects Mindray's current and preliminary views, which are subject to change.

"The revised guidance reflects more cautious assumptions of the overall market conditions for the remainder of 2009, as the world industry dynamics continued to worsen since earlier this year," commented Mr. Li Xiting, Mindray's president and co-chief executive officer. "For the current year, the China market still represents the strongest growth outlook. The picture outside China is mixed though, with healthy growth from Latin America and Africa coupled with additional growth as a result of our acquisition of our Mahwah operations, partially offset by declines in other sales geographies outside of China. We remain firm in our belief that Mindray's unique vertically integrated business model and strong financial position will allow us to more effectively adapt to fast changing market environments such as the one we are in today. We will continue to build on our cost advantages coupled with effective R&D and solid sales infrastructure to capture substantial growth opportunities in the markets we compete in."

In addition, as announced on March 4, 2009, Mr. Ronald Ede began in his new role of Chief Financial Officer of the company effective on May 8, 2009, replacing Ms. Joyce Hsu. Mr. Ede and Ms. Hsu both remain directors serving on Mindray's board.

Conference Call Information

Mindray's management will hold an earnings conference call at 8:00 AM on May 12, 2009 U.S. Eastern Time (8:00 PM on May 12, 2009 Beijing/Hong Kong Time).

    Dial-in details for the earnings conference call are as follows:

    Hong Kong:                 +852-3002-1672
    U.S. Toll Free:            +1-800-798-2864
    International:             +1-617-614-6206
  
'/>"/>
SOURCE Mindray Medical International Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Mindray Files Annual Report on Form 20-F with U.S. Securities and Exchange Commission
2. Mindray to Report First Quarter 2009 Financial Results on May 11, 2009
3. Mindray Medical to Exhibit New Products at 61st China International Medical Equipment Fair
4. Mindray Announces Option Exchange Offer
5. Mindray to Report Fourth Quarter and Fiscal Year 2008 Financial Results on March 4, 2009
6. Mindray Medical Achieves 2008 Product Development Goals and Announces Strong Pipeline for 2009
7. Mindray Announces Preliminary 2008 Operating Results
8. Mindray Medical to Present at the 27th Annual J.P. Morgan Healthcare Conference
9. Mindray Medical to Exhibit at RSNA 2008 in Chicago, from November 30th to December 4th, 2008
10. Mindray Announces 2008 Third Quarter and Nine Months Results
11. Mindray to Report Third Quarter 2008 Financial Results on November 11, 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... when taking sedatives, antidepressants, benzodiaz...4 (HealthDay News) -- Seniors who take antidepress... may be at increased risk for falls, a new review ...shed studies that included a total of 79,081 parti...classes of drugs: high blood pressure medicines; d...
(Date:11/24/2009)...LARA,Calif.,Nov.24/PRNewswire/--AgitoNetworks,Inc....semobility,todayannouncedthatitwashonoredintheEver...RoamAnywhereMobilityRouterv3.0.EverythingChannel,s...aveintroducednewsolutionsthatdriveadvancesthrougho...estCenterreviewedhundredsofapplicationsforthe2009E...
(Date:11/24/2009)...GTON,Nov.24/PRNewswire/--TheUnionLaborLifeInsuranc...lignedwithVSP(®),()thenation,slargestvisionbe...suranceproductstounions,uniontrustfunds,unionemplo...spointsofferingservicesincludingcomprehensiveeyeex...standhowimportantqualityeyecareis,"statedBruceSmit...
(Date:11/24/2009)...at quitting improves heart prospects, but cancer r...Day News) -- A new study offers yet more proof tha...art disease and cancer. , Researchers followed ...rs, formers smokers and nonsmokers for three years...s more likely to die of cancer, 2.26 times more li...
(Date:11/24/2009)... an example, study finds no added use but higher c...s) -- Direct-to-consumer drug ads may contribute t...that examined sales of the widely used antiplatele...data from 1999 to 2005 for 27 state Medicaid progr...clopidogrel did not increase people,s use of the d...
Breaking Medicine News(10 mins):Health News:Some Prescription Meds May Raise Seniors' Risks of Falling 2Health News:Agito Networks Recognized in the 2009 Tech Innovators Awards Program by Everything Channel 2Health News:Agito Networks Recognized in the 2009 Tech Innovators Awards Program by Everything Channel 3Health News:Union Labor Life & VSP Vision Care Align to Offer Vision Insurance Products 2Health News:Smokers Double Their Risk for Heart Disease 2Health News:Advertising to Consumers May Raise Drug Prices 2
...oem, "Do not go gentle into that good night," Dyla... of the light." Researchers are now backing up thi...ainst threats to one,s health is critical to good ...n an effort to prevent further decline. The elderl...
...egie Mellon University,s Ender Finol has received ...itutes of Health (NIH) to develop methodologies fo...uring in the human body,s main artery, which carri...vital cargoes of blood through more than 60,000 mi...
...h Crohn,s & Colitis Foundation of America for this...t, KANSAS CITY, Mo., June 12 The Crohn,s & Colit...ce that Salix,Pharmaceuticals, a leader in gastroe...b of Kansas City. The 5K walk,begins after the fes...
...June 12 Canary Foundation, a,nonprofit organizati...and,the American Cancer Society announced the five...Cancer Society Early Detection Postdoctoral,Fellow...number of fellows sponsored since the program,s in...
...who were outside the norm faced higher mortality r... -- A new study suggests that older men with abnor...ath. , The findings aren,t conclusive, and they do... , "If people think they have disruptions in thei...
...m for Martial Arts Schools about Diabetes Awarenes...ndation,announced the launch of their next diabete...R) Community Action Project (MADDCAP(TM)), a histo...tion between Defeat Diabetes Foundation Executive ...
Other Medicine News:Health News:Study pinpoints strategies that protect older adult's physical health 2Health News:Carnegie Mellon researchers improve assessments of aortic aneurysms 2Health News:National Pharmaceutical Company to Sponsor Popular Indianapolis Walk 2Health News:National Pharmaceutical Company to Sponsor Popular Indianapolis Walk 3Health News:Canary Foundation and American Cancer Society Award Five Postdoctoral Fellowships in Early Cancer Detection 2Health News:Canary Foundation and American Cancer Society Award Five Postdoctoral Fellowships in Early Cancer Detection 3Health News:Canary Foundation and American Cancer Society Award Five Postdoctoral Fellowships in Early Cancer Detection 4Health News:Abnormal Sleep Patterns in Older Men Spell Trouble 2Health News:Defeat Diabetes Foundation Announces Martial Arts Defeat Diabetes(R) Community Action Project(TM) 2
(Date:11/24/2009)...24/PRNewswire/--AmbitBiosciencesCorporationannounc...ingAC220,anovelsecondgenerationFLT3inhibitor,inAML...ASH)tobeheldinNewOrleans,LA,December5-8,2009.Anora...icalPhaseImonotherapysafetystudyinadultswithacutem...illbepresentedevaluatingtheeffectofAC220monotherap...
(Date:11/24/2009)....,Nov.24/PRNewswire-FirstCall/--EchoTherapeutics,I...edle-freeSymphony(TM)tCGMSystemasanon-invasive,wir...systemanditsPrelude(TM)SkinPrepSystemfortransderma...D.,ChairmanandChiefExecutiveOfficer,willpresentatt...erence,sponsoredbytheNewYorkSocietyofSecuritiesAna...
(Date:11/24/2009)...v.24/PRNewswire/--MAQUETCardiovascularLLC,aleading...ythatithassignedaguaranteedtwo-yearcontractwithNov...zations,tobethesolesourceproviderofsurgicaldevices...oftheagreement,whichrunsthroughOctober31,2012,MAQU...gheartdevicesanddisposablesuppliestothemembersofVH...
Breaking Medicine Technology:Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 2Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 3Echo Therapeutics to Present at the New York Society of Security Analysts' 13th Annual Biotech and Specialty Pharmaceuticals Conference 2MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 2MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 3New lab on a chip technique developed at U of T 14419 1New lab on a chip technique developed at U of T 14419 2Researchers create smaller and more efficient nuclear battery 14417 1Researchers create smaller and more efficient nuclear battery 14417 2The Truth About Bad Breath 59249 1The Truth About Bad Breath 59249 2
...announced that the U.S. Food and Drug Administrati...ction Concentrate in combination with cisplatin,an...advanced squamous cell,carcinoma of the head and n...apy and surgery. The FDA based its approval on th...international trial, TAX 324, which established th...
...n / Triage Test for Human,Appendicitis, Advances i...g Sensitivity Level of 98%.,...c. (Nasdaq: APPY ) an emerging bio-pharmaceutical...gs and diagnostics for animals and humans, today,a...lti-hospital study using,its AppyScore(TM) human a...
Other Medicine Technology:Taxotere(R) (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery 2Taxotere(R) (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery 3Taxotere(R) (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery 4AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study 2AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study 3AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study 4AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study 5AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study 6AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study 7AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study 8AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study 9
Synchron
Metrika's AC1Now Monitor
Advia WorkCell CDX Modular Automation
Cascade M-4 Manual Coagulation Analyzer
Medicine Products: